PERFECT Project - Part 2 - Study 2

NCT02370927 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-01-26

No results posted yet for this study

Summary

The objectives are to test the acute effects of different cereals containing pulse ingredients on: 1) aerobic endurance and substrate oxidation during exercise 2) response of blood glucose, insulin and appetite to an aerobic exercise session, and 3) food intake two hours following the exercise session. The investigators hypothesize that consumption of cereals containing pulse ingredients 60 minutes before exercise will increase aerobic endurance (lower oxygen consumption), decrease carbohydrate oxidation (greater respiratory quotient), and a reduction in lactate production during compared to the same exercise session following the ingestion of a non-pulse food. The investigators also hypothesize that consumption of cereals containing pulse ingredients will lead to lower blood glucose, insulin, appetite and food intake, suggesting lower calorie compensation, following a 60-minute aerobic exercise session compared to the same exercise session following the ingestion of a non-pulse food.

Conditions

  • Diabetes Prevention
  • Obesity Prevention

Interventions

OTHER

Control

Non pulse extruded cereal

OTHER

Pea protein

Pulse extruded cereal

OTHER

Pea Starch

Pulse extruded cereal

OTHER

Pea fibre + pea starch

Pulse extruded cereal

OTHER

Pea protein + pea starch

Pulse extruded cereal

OTHER

Pea fibre + pea starch + pea protein

Pulse extruded cereal

Sponsors & Collaborators

  • Saskatchewan Pulse Growers

    collaborator OTHER
  • Alberta Pulse Growers

    collaborator OTHER
  • University of Manitoba

    lead OTHER

Principal Investigators

  • Peter JH Jones, PhD · University of Manitoba, Richardson Centre for Functional Foods and Nutraceuticals

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-07-31
Completion
2017-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02370927 on ClinicalTrials.gov